| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.6M | $4.3M | $1.8M |
| YoY Revenue Growth % | -14.6% | +134.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$97.5M | -$258.4M | -$318.9M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$127.1M | -$251.4M | -$267.6M |
| EBITDA (Normalized) | -$97.1M | -$257.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$50.6M | -$58.0M | -$46.2M |
| Capital Expenditures (CapEx) | $578.0K | $808.0K | — |
| Free Cash Flow (FCF) | -$51.2M | -$58.9M | -$46.2M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $9.9M | $14.4M | — |
| Total Debt (Short + Long Term) | $93.0K | $226.0K | — |
| Total Stockholders' Equity | $21.8M | $92.2M | — |